EC Guidance Issued on Listeria Monocytogenes for EU Ready-to-Eat Foods
New European Commission guidance details compliance with updated L. monocytogenes criteria, effective 1 July 2026, impacting ready-to-eat food manufacturers across the EU.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Dublin, Ireland — 08 January 2026
The European Commission has published updated guidance for food businesses on Listeria monocytogenes monitoring and shelf-life studies, ahead of new regulations taking effect on 1 July 2026. Commission Regulation (EU) 2024/2895 amends previous microbiological criteria, specifically addressing a legislative gap for Category 1.2 ready-to-eat (RTE) foods capable of supporting L. monocytogenes growth. Previously, these products lacked a specific L. monocytogenes limit if sampled post-production and unable to demonstrate compliance with a 100 cfu/g limit throughout their shelf-life. The updated regulation extends the 'not detected in 25g' criterion to these specific RTE food categories.
The guidance is primarily aimed at food business operators producing RTE foods that require L. monocytogenes shelf-life studies under Article 3(2) and Annex II of Commission Regulation (EC) No 2073/2005. It provides critical recommendations for manufacturers on product classification and labelling, determining applicable L. monocytogenes food safety criteria, and deciding when and which shelf-life studies are necessary. Furthermore, it outlines how to demonstrate compliance with L. monocytogenes criteria until the end of a product's shelf-life, and how to validate, verify, and document the adequacy of such studies.
Food businesses manufacturing RTE products susceptible to L. monocytogenes growth and not undergoing pathogen-eliminating heat treatment must rigorously prove product compliance throughout its shelf-life. This requires a comprehensive understanding of L. monocytogenes growth behaviour within their specific product matrices to establish safe shelf-life parameters. The guidance is also a resource for competent authorities overseeing official controls and third parties involved in developing shelf-life studies.
What this means for Ireland
Irish manufacturers of ready-to-eat foods face immediate compliance updates to their quality control and product development processes. By 1 July 2026, all relevant products must adhere to the 'not detected in 25g' L. monocytogenes criterion, requiring significant investment in new shelf-life studies and reassessment of existing product formulations. Procurement leads must anticipate potential reformulation windows and increased testing costs, which could compress margins by 5-10% without price adjustments. Brand owners must ensure stringent supplier vetting and validation to mitigate recall risks under FSAI scrutiny, particularly for products with complex supply chains.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.